International survey on COVID-19 effects
International Survey of Acute Coronavirus Syndromes (ISACS)-COVID-19
University of Bologna · NCT05188612
This study is trying to understand how COVID-19 affects people who were hospitalized by collecting information about their health after they leave the hospital or if they pass away.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Bologna (other) |
| Locations | 2 sites (Bologna, Bologna and 1 other locations) |
| Trial ID | NCT05188612 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry to gather data on the impact of COVID-19 on patients who have been hospitalized. It involves collaboration among researchers from the University of Bologna and various Central and Eastern European countries to address knowledge gaps regarding cardiovascular disease (CVD) in the context of COVID-19. The study focuses on patients who have been admitted to healthcare centers with confirmed COVID-19 infections, collecting information on their health outcomes post-discharge or at the time of death. The initiative emphasizes the importance of coordination and information-sharing among researchers to enhance understanding and treatment of COVID-19.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been hospitalized with a confirmed diagnosis of COVID-19.
Not a fit: Patients who are underage or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effects of COVID-19 on cardiovascular health, potentially guiding future treatment and prevention strategies.
How similar studies have performed: Other studies have shown success in similar observational approaches to understanding the effects of COVID-19, indicating that this methodology is both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years (male or female) * Patients admitted to any hospital center with a confirmed diagnosis of COVID-19 infection. Exclusion Criteria: • Underage or not able to give informed consent
Where this trial is running
Bologna, Bologna and 1 other locations
- University of Bologna — Bologna, Bologna, Italy (RECRUITING)
- IR-Hospital de la Santa Creu i Sant Pau, UAB — Barcelona, Spain (RECRUITING)
Study contacts
- Study coordinator: Raffaele Bugiardini, MD
- Email: raffaele.bugiardini@unibo.it
- Phone: +39 051 347290
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COVID-19